Identification of regions within the F domain of the human estrogen receptor α that are important for modulating transactivation and protein-protein interactions

Molecular Endocrinology

Volumn 21, Issue 4, 2007, Pages 829-842

  Koide, Akiko ^a   Zhao, Changqing ^b   Naganuma, Misuzu ^a   Abrams, Judith ^c   Deighton Collins, Sarah ^b   Skafar, Debra F ^b,c   Koide, Shohei ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; LEUCYLGLUTAMINYLLYSYLTYROSYLTYROSYLISOLEUCYLTHREONINE; PEPTIDE FRAGMENT; STEROID RECEPTOR COACTIVATOR 1; UNCLASSIFIED DRUG; 4-HYDROXYTAMOXIFEN; DRUG DERIVATIVE; HISTONE ACETYLTRANSFERASE; PRESENILIN 2; PSEN2 PROTEIN, HUMAN; TAMOXIFEN; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; HYDROPHOBICITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN ENGINEERING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TRANSACTIVATION; TWO HYBRID SYSTEM; WILD TYPE; CELL CULTURE; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; POINT MUTATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE;

MAMMALIA;

AMINO ACID SEQUENCE; CELLS, CULTURED; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HISTONE ACETYLTRANSFERASES; HUMANS; MOLECULAR SEQUENCE DATA; POINT MUTATION; PRESENILIN-2; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; TAMOXIFEN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 34247889975     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2006-0203     Document Type: Article

References (52)

1. Nilsson S, Gustafsson JA 2000 Estrogen receptor transcription and transactivation: Basic aspects of estrogen action. Breast Cancer Res 2:360-366
2. Katzenellenbogen BS, Katzenellenbogen JA 2000 Estrogen receptor transcription and transactivation. Estrogen receptor α and estrogen receptor β: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res 2:335-344
3. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P 1987 Functional domains of the human estrogen receptor. Cell 51:941-951
4. Wang C, Fu M, Angeletti RH, Siconolfi-Baez L, Reutens AT, Albanese C, Lisanti MP, Katzenellenbogen BS, Kato S, Hopp T, Fuqua SA, Lopez GN, Kushner PJ, Pestell RG 2001 Direct acetylation of the estrogen receptor α hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem 276:18375-18383
5. Birnbaumer M, Schrader WT, O'Malley BW 1983 Assessment of structural similarities in chick oviduct progesterone receptor subunits by partial proteolysis of photoaffinity-labeled proteins. J Biol Chem 258:7331-7337
6. Dahlman-Wright K, Baumann H, McEwan IJ, Almlof T, Wright AP, Gustafsson JA, Hard T 1995 Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor. Proc Natl Acad Sci USA 92:1699-1703
7. Bain DL, Franden MA, McManaman JL, Takimoto GS, Horwitz KB 2000 The N-terminal region of the human progesterone A-receptor. Structural analysis and the influence of the DNA binding domain. J Biol Chem 275:7313-7320
8. Warnmark A, Wikstrom A, Wright AP, Gustafsson JA, Hard T 2001 The N-terminal regions of estrogen receptor α and β are unstructured in vitro and show different TBP binding properties. J Biol Chem 276:45939-45944
9. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
10. Mosselman S, Polman J, Dijkema R 1996 ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53
11. Montano MM, Muller V, Trobaugh A, Katzenellenbogen BS 1995 The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol Endocrinol 9:814-825
12. Weatherman RV, Scanlan TS 2001 Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERα and ERβ) at AP-1 sites. J Biol Chem 276:3827-3832
13. Warnmark A, Almlof T, Leers J, Gustafsson JA, Treuter E 2001 Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERα and ERβ. J Biol Chem 276:23397-23404
14. Kim K, Thu N, Saville B, Safe S 2003 Domains of estrogen receptor α (ERα) required for ERα/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells. Mol Endocrinol 17:804-817
15. Schwartz JA, Zhong L, Deighton-Collins S, Zhao C, Skafar DF 2002 Mutations targeted to a predicted helix in the extreme carboxyl-terminal region of the human estrogen receptor-α alter its response to estradiol and 4-hydroxytamoxifen. J Biol Chem 277:13202-13209
16. Loven MA, Muster N, Yates JR, Nardulli A 2003 A novel estrogen receptor α-associated protein, template-activating factor Iβ, inhibits acetylation and transactivation. Mol Endocrinol 17:67-78
17. Nichols M, Rientjes J M, Stewart AF 1999 Different positioning of the ligand-binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists. EMBO J 17:765-773
18. Peters GA, Khan SA 1999 Estrogen receptor domains E and F: role in dimerization and interaction with coactivator RIP-140. Mol Endrocrinol 13:286-296
19. Koide A, Bailey CW, Huang X, Koide S 1998 The fibronectin type III domain as a scaffold for novel binding proteins. J Mol Biol 284:1141-1151
20. Koide A, Abbatiello S, Rothgery L, Koide S 2002 Probing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor. Proc Natl Acad Sci USA 99:1253-1258
21. Richards J, Miller M, Abend J, Koide A, Koide S, Dewhurst S 2003 Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human αvβ3 integrin. J Mol Biol 326:1475-1488
22. Zhao C, Koide A, Abrams J, Deighton-Collins S, Martinez A, Schwartz JA, Koide S, Skafar DF 2003 Mutation of Leu-536 in human estrogen receptor-α alters the coupling between ligand binding, transcription activation, and receptor conformation. J Biol Chem 278:27278-27286
23. Gyuris J, Golemis E, Chertkov H, Brent R 1993 Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75:791-803
24. Pakdel F, le Goff P, Katzenellenbogen BS 1993 An assessment of the role of domain F and PEST sequences in estrogen receptor half-life and bioactivity. J Steroid Biochem Mol Biol 46:663-672
25. Lonard DM, Nawaz Z, Smith CL, O'Malley BW 2000 The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation. Mol Cell 5:939-948
26. Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
27. Bocquel MT, Kumar V, Chambon P, Gronemeyer H 1989 The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. Nucleic Acids Res 17:2581-2595
28. Needham M, Raines S, McPheat J, Stacey C, Ellston J, Hoare S, Parker M 2000 Differential interaction of steroid hormone receptors with LXXLL motifs in SRC-1a depends on residues flanking the motif. J Steroid Biochem Mol Biology 72:35-46
29. Kalkhoven E, Valentine JE, Heery DM, Parker MG 1998 Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO Journal 17:232-243
30. Sheppard HM, Matsuda S, Harries JC, Kindle KB, Heery DM 2003 Transcriptional activation by estrogen receptor (ERα) and steroid receptor coactivator (SRC1) involves distinct mechanisms in yeast and mammalian cells. J Mol Endocrinol 30:411-422
31. Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL 2002 Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol 9:359-364
32. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JA, Carlquist M 1999 Structure of the ligand-binding domain of oestrogen receptor β in the presence of a partial agonist and a full antagonist. EMBO J 18:4608-4618
33. Williams SP, Sigler PB 1998 Atomic structure of progesterone complexed with its receptor. Nature 393:392-396
34. Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y, Wu GY, Scheffler JE, Salvati ME, Krystek Jr SR, Weinmann R, Einspahr HM 2001 Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci USA 98:4904-4909
35. Kauppi B, Jakob C, Farnegardh M, Yang J, Ahola H, Alarcon M, Calles K, Engstrom O, Harlan, J, Muchmore S, Ramqvist AK, Thorell S, Ohman L, Greer J, Gustafsson JA, Carlstedt-Duke J, Carlquist M 2003 The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J Biol Chem 278:22748-22754
36. Farboud B, Privalsky M 2004 Retinoic acid receptor-α is stabilized in a repressive state by its C-terminal, isotypespecific F domain. Mol Endocrinol 18:2839-2853
37. Norris JD, Paige LA, Christensen DJ, Chang C-Y, Huacani MR, Fan D, Hamilton PT, Fowlkes DM, McDonnell DP 1999 Peptide antagonists of the human estrogen receptor. Science 285:744-746
38. Kong EH, Heldring N, Gustafsson JA, Treuter E, Hubbard RE, Pike ACW 2005 Delineation of a unique protein-protein interaction site on the surface of the estrogen receptor. Proc Natl Acad Sci USA 102:3593-3598
39. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (Lond) 390:753-758
40. Shiau AK, Barstad D, Loria, PM, Cheng L, Kushner PJ, Agard DA, Greene GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937
41. Pratt WB, Toft DO 1997 Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18:306-360
42. Johnson JL, Craig EA 1997 Protein folding in vivo: unraveling complex pathways. Cell 90:201-204
43. Fang Y, Fliss AE, Rao J, Caplan AJ 1999 SBA1 encodes a yeast hsp90 cochaperone that is homologous to vertebrate p23 proteins. Mol Cell Biol 18:3727-3734
44. Fliss AE, Benzeno S, Rao J, Caplan AJ 2000 Control of estrogen receptor ligand binding by Hsp90. J Steroid Biochem Mol Biol 72:223-230
45. Sladek FM, Ruse MD, Nepomuceno L, Huang SH, Stallcup MR 1999 Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4α1. Mol Cell Biol 19:6509-6522
46. Bogan AA, Dallas-Yang Q, Ruse MD, Maeda Y, Jiang G, Nepomuceno L, Scanlan TS, Cohen FE, Sladek FM 2000 Analysis of protein dimerization and ligand binding of orphan receptor HNF4α. J Mol Biol 302:831-851
47. Ruse MD, Privalsky ML, Sladek FM 2002 Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4α1: modulation by the F domain. Mol Cell Biol 22:1626-1638
48. Hani EH, Suaud L, Boutin P, Chevre JC, Durand E, Philippi A, Demenais F, Vionnet N, Furuta H, Velho G, Gell GI, Laine B, Froguel P 1998 A missense mutation in hepatocyte nuclear factor-4α, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. J Clin Invest 101:521-526
49. Finley Jr RL, Brent R 1994 Interaction mating reveals binary and ternary connections between Drosophila cell cycle regulators. Proc Natl Acad Sci USA 91:12980-12984
50. Harrell Jr FE 2001 Regression modeling strategies: with applications to linear models, logistic regression and survival analysis. New York: Springer-Verlag
51. Holm S 1997 A simple sequentially rejective multiple test procedure. Scand J Stat 6:65-70
52. Sambrook J, Fritsch EF, Maniatis T 2001 Molecular cloning: A laboratory manual. 3rd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory